Dr. West Discusses Chemotherapy Without Driver Mutations in NSCLC OncLive 1:54 6 years ago 94 Далее Скачать
Current treatment options for NSCLC without driver mutations VJOncology 2:21 1 year ago 189 Далее Скачать
The Role of Driver Mutations in NSCLC Treatment - 2022 Program: LCVL GRACE - Global Resource for Advancing Cancer Education 5:29 1 year ago 146 Далее Скачать
Treating Advanced Lung Cancer in Patients Without Driver Mutations Targeted Oncology 4:44 6 years ago 133 Далее Скачать
Introducing novel immunotherapeutic approaches for metastatic NSCLC without driver mutations Touch Medical Media 47:52 1 year ago 100 Далее Скачать
Dr. West on FDA Approval of Frontline Osimertinib in EGFR+ NSCLC OncLive 3:14 7 years ago 216 Далее Скачать
Dr. West Discusses Upcoming Important Clinical Trials Results OncLive 1:35 13 years ago 339 Далее Скачать
Dr. West on Emerging Changes in the Field of EGFR-Mutant NSCLC OncLive 0:59 7 years ago 213 Далее Скачать
Dr. West Discusses Afatinib and Cetuximab Combination in NSCLC OncLive 0:51 13 years ago 793 Далее Скачать
Dr. West Discusses Latest Immunotherapy Findings in Lung Cancer OncLive 1:50 6 years ago 349 Далее Скачать
Dr. West on FDA Approval of Afatinib in NSCLC With Rare EGFR Mutations OncLive 1:47 7 years ago 398 Далее Скачать
Copy of Dr. West on FDA Approval of Frontline Osimertinib in EGFR+ NSCLC OncLive 0:40 6 years ago 39 Далее Скачать
Choosing immunotherapy as front line therapy for non-actionable NSCLC VJOncology 3:08 2 years ago 94 Далее Скачать
Any role of Chemotherapy in high PDL1 metastatic non-small cell lung cancer in 1L? OncBrothers: Practice-Changing Cancer Discussions 0:53 3 months ago 226 Далее Скачать
